Communicable Diseases and Epidemiological Determinants
🟢 Lite — Quick Review (1h–1d)
Rapid summary for last-minute revision before your exam.
Communicable Diseases and Epidemiological Determinants — Key Facts for FMGE Core concept: Understanding the chain of infection and modes of transmission is essential for disease prevention and control High-yield point: The “host-agent-environment” model (epidemiological triad) explains how diseases spread; breaking any link prevents transmission ⚡ Exam tip: Know the incubation periods and characteristic presentations of major communicable diseases and their prevention strategies
🟡 Standard — Regular Study (2d–2mo)
Standard content for students with a few days to months.
Communicable Diseases and Epidemiological Determinants — FMGE Study Guide
Chain of Infection
Steps in Chain
- Pathogen (Infectious Agent): Bacteria, virus, fungus, parasite
- Reservoir: Where the agent lives and multiplies (humans, animals, environment)
- Portal of Exit: How the agent leaves the reservoir (respiratory, GI, blood, skin)
- Mode of Transmission: How the agent reaches the host
- Portal of Entry: How the agent enters the new host
- Susceptible Host: Person who can acquire the infection
Breaking the Chain
- Eliminate reservoir: Treatment, isolation, culling animals
- Block exit: Hand hygiene, masks, wound care
- Prevent transmission: Quarantine, disinfection, vector control
- Block entry: PPE, vaccination, prophylaxis
- Protect host: Vaccination, healthy lifestyle, chemoprophylaxis
Modes of Transmission
Direct Transmission
- Direct contact: Touching, biting, sexual contact
- Droplet spread: Large droplets (>5 μm) travel <1 meter (coughing, sneezing, talking)
- Examples: Influenza, meningitis, pertussis
- Vertical transmission: Mother to child (transplacental, during birth, breastfeeding)
Indirect Transmission
- Vehicle-borne: Contaminated food, water, blood, objects (fomites)
- Vector-borne: Insects (mosquitoes, flies, ticks)
- Mechanical: On legs/body surface
- Biological: Multiplication in vector (malaria in Anopheles)
- Airborne: Small droplets (<5 μm) remain suspended and travel >1 meter
- Examples: Measles, varicella, TB, COVID-19
- Droplet nuclei: Evaporated droplets that become small enough to be inhaled
Herd Immunity
- When enough people in a population are immune, chain of transmission breaks
- Herd immunity threshold: Varies by disease (measles ~95%, polio ~80%)
- Achieved through vaccination or natural infection
Classification of Diseases
Endemic
- Constant presence of a disease in a geographic area at a consistent rate
- Example: Malaria in certain tropical regions
Epidemic
- Increase in cases above expected baseline in a defined area/population
- Example: COVID outbreak in Wuhan, influenza outbreaks
Pandemic
- Global spread of a new disease across countries/continents
- Examples: COVID-19, H1N1 influenza 2009, HIV/AIDS
Outbreak
- Similar to epidemic but often more localized or contained
Zoonosis
- Diseases transmitted from animals to humans
- Examples: Rabies, brucellosis, plague, avian influenza
Nosocomial Infections
- Infections acquired in hospital (hospital-acquired/associated)
- Common pathogens: E. coli, Staphylococcus aureus, Pseudomonas
- Surgical site infections, UTIs (most common), pneumonia, bloodstream infections
Specific Communicable Diseases
Tuberculosis
- Causative agent: Mycobacterium tuberculosis (acid-fast bacillus)
- Mode of transmission: Airborne (droplet nuclei)
- Incubation period: Weeks to years (initial infection → primary TB)
- Types: Primary TB (lower lobe, Ghon complex), Secondary/reactivation TB (apical cavitary)
- Diagnosis: AFB smear, sputum culture, GeneXpert, Mantoux test (PPD)
- BCG vaccine: Live attenuated M. bovis; not fully protective
- DOTS: Directly observed treatment, short-course - WHO strategy
HIV/AIDS
- Mode of transmission: Sexual, blood, vertical (mother to child)
- Window period: 2 weeks to 3 months (antibodies not yet detectable)
- Diagnosis: ELISA (screening), Western blot (confirmatory), rapid tests
- Prevention: ABC (Abstinence, Be faithful, Condoms), PMTCT, blood safety, harm reduction
- ART (Antiretroviral therapy): Reduces viral load, prevents transmission, improves survival
- Opportunistic infections: PCP (pneumocystis jirovecii pneumonia), oral candidiasis, toxoplasmosis, cryptococcal meningitis, TB
Viral Hepatitis
- Hepatitis A: Fecal-oral; acute; no chronic carrier state; fecal-oral
- Hepatitis B: Blood, sexual, vertical; chronic carrier state; HBV vaccine available
- Hepatitis C: Blood; chronic carrier state; no vaccine
- Hepatitis E: Fecal-oral; especially dangerous in pregnancy
Cholera
- Causative agent: Vibrio cholerae (comma-shaped bacterium)
- Mode: Water contamination; fecal-oral
- Presentation: Rice-water stools, severe dehydration
- Treatment: ORS, antibiotics (azithromycin, doxycycline)
- Prevention: Water treatment, sanitation, ORS preparation education
Dengue
- Vector: Aedes aegypti mosquito
- Presentation: High fever, headache, retro-orbital pain, rash, thrombocytopenia
- Dengue hemorrhagic fever: Plasma leakage, bleeding, shock
- Prevention: Mosquito control, personal protection (repellents, nets)
Malaria
- Vector: Anopheles mosquito
- Species: P. falciparum (most dangerous), P. vivax, P. ovale, P. malariae, P. knowlesi
- Presentation: Cyclic fevers (tertian/quartan depending on species)
- Treatment: ACT (artemisinin-based combination therapy) for P. falciparum
- Prevention: ITNs (insecticide-treated nets), IRS (indoor residual spraying), chemoprophylaxis
Typhoid
- Causative agent: Salmonella typhi
- Mode: Fecal-oral; chronic carriers (Mrs. Mallon/Typhoid Mary)
- Presentation: Step-ladder fever, rose spots, hepatosplenomegaly
- Diagnosis: Widal test, blood/stool culture
- Vaccine: Ty21a (oral), Vi polysaccharide (injectable)
Immunization
Types of Immunity
- Active: Body produces antibodies; long-lasting; takes time to develop
- Passive: Preformed antibodies given; immediate but short-lasting
Vaccine Types
- Live attenuated: MMR, Varicella, Rotavirus, BCG, Yellow fever, Oral polio
- Inactivated/Killed: Hepatitis A, Influenza (injection), Rabies, IPV
- Toxoid: Tetanus, Diphtheria (inactivated toxin)
- Polysaccharide/Conjugate: Hib, Pneumococcal, Meningococcal (T-cell independent - less durable)
- mRNA/Viral vector: COVID-19 vaccines
National Immunization Schedule (India)
- BCG: At birth
- Hep B: At birth
- OPV: At birth, 6, 10, 14 weeks
- DPT: 6, 10, 14 weeks
- Hib: 6, 10, 14 weeks
- Rotavirus: 6, 10, 14 weeks
- IPV: 14 weeks
- MR: 9 months
- Vitamin A: 9 months
- Japanese Encephalitis: In endemic areas
- DPT booster: 16-24 months, 5-6 years
Content adapted based on your selected roadmap duration. Switch tiers using the selector above.